Marketing-authorisation holder · United States
Xiromed
28 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 28
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACYCLOVIR5% · Ointment | Aciclovir | United States | Marketed | 2013 |
| ALTAVERA0.03mg; 0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2010 |
| ELIFEMME0.03mg,0.04mg,0.03mg; 0.05mg,0.075mg,0.125mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 2015 |
| ENILLORING0.015mg/24hr; 0.12mg/24hr · Ring | Ethinyl estradiol, Etonogestrel | United States | Marketed | 2023 |
| ESTARYLLA0.035mg; 0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2013 |
| ESTRADIOL VALERATE10mg/ml | 20mg/ml | 40mg/ml · Injectable | Estradiol | United States | Marketed | 1979 |
| ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL0.035mg; 1mg | 0.05mg; 1mg · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Marketed | 2016 |
| FOSFOMYCIN TROMETHAMINE3gm base/packet · For solution | Fosfomycin | United States | Marketed | 2020 |
| GEMMILY0.02mg; 1mg · Capsule | Ethinyl estradiol, Norethindrone | United States | Marketed | 2020 |
| INTROVALE0.03mg; 0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2010 |
| ISIBLOOM0.15mg; 0.03mg · Tablet | Desogestrel, Ethinyl estradiol | United States | Marketed | 2015 |
| JAIMIESS0.03mg,0.01mg; 0.15mg,n/a · Tablet | Ethinyl estradiol, Levonorgestrel, N/a | United States | Marketed | 2017 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL0.02mg; 0.1mg | 0.03mg,0.04mg,0.03mg; 0.05mg,0.075mg,0.125mg | 0.03mg; 0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2003 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE0.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2023 |
| LORYNA3mg; 0.02mg · Tablet | Drospirenone, Ethinyl estradiol | United States | Marketed | 2011 |
| NORETHINDRONE0.35mg · Tablet | Norethindrone | United States | Marketed | 2010 |
| NORETHINDRONE ACETATE5MG · Tablet | Norethindrone | United States | Marketed | 2001 |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL0.02mg,0.03mg,0.035mg; 1mg,1mg,1mg | 0.02mg; 1mg | 0.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2010 |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE0.01mg,0.01mg; 1mg,n/a · Tablet | Ethinyl estradiol, Norethindrone, N/a | United States | Not marketed | 2016 |
| NORETHINDRONE AND ETHINYL ESTRADIOL0.035mg,0.035mg,0.035mg; 0.5mg,0.75mg,1mg | 0.035mg; 0.4mg | 0.035mg; 0.5mg | 0.035mg; 1mg | 0.05mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 1987 |
| NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE0.025mg; 0.8mg · Tablet, chewable | Ethinyl estradiol, Norethindrone | United States | Marketed | 2010 |
| OMEPRAZOLE10mg | 20mg | 40mg · Capsule, delayed rel pellets | Omeprazole | United States | Marketed | 2002 |
| PROGESTERONE100mg | 200mg · Capsule | Progesterone | United States | Marketed | 2012 |
| SYEDA3mg; 0.03mg · Tablet | Drospirenone, Ethinyl estradiol | United States | Marketed | 2011 |
| TRI-ESTARYLLA0.035mg,0.035mg,0.035mg; 0.18mg,0.215mg,0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2013 |